Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Emotional eating and body dissatisfaction mediate links between BMI changes and mental health. These psychosocial factors ...

The report by Apollo Hospitals zeroes in on three urgent health issues: fatty liver disease, post-menopausal health decline, ...

BENGALURU: Over half of Karnataka’s population screened in 2024 was either obese or overweight, with 56% diagnosed as obese ...

Those without these symptoms are not let off scot-free. They are assigned to a limbo called “preclinical obesity” since, though not ill, they are reckoned to have an increased risk of ...

The condition may not trigger warning signs immediately, but untreated MASLD can lead to serious complications, including ...

Amy Schumer shared she quit Wegovy due to side effects like nausea but was "having a really good experience" with Mounjaro, ...

"This drug improves kidney function, obesity and HFpEF outcomes ... worsening heart failure (defined as worsening heart failure symptoms in addition to hospitalization or the intensification ...

A new report by Apollo Hospitals reveals that millions of Indians are living with undiagnosed chronic conditions like ...

Study underscores the direct vascular effects of this class of drugs, researchers say AURORA, CO / ACCESS Newswire / March 29, 2025 / A novel study of a semaglutide, a glucagon-like peptide-1 (GLP-1) ...